Bitcoin's 30-day average of active addresses fell 43% from its December 2024 peak to about 629,000 by November 1, while the daily transfer volume dropped only about 5% in the same period. Active addresses averaged 1.1 million at the peak but declined more sharply than transfer volume, which remained 5.5% above its yearly average. This divergence suggests fewer unique users but steady transaction amounts. Both metrics decreased slightly in the past week, indicating a cooling in network activity over nearly two years.
Bitcoin's active address trend provides context for readers. As of Nov 02, 2026 16:21 WIB, 7 of 50 major cryptocurrencies on Pluang rose, 42 fell. THETA dropped 3.62% to Rp2.798 with 61% sell orders; AAVE fell 3.57% to Rp2.402.961 with 72% sell orders; CRV declined 3.52% to Rp4.992 with 57% sell orders.
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
A SEON survey of 2,026 U.S. adults reveals that while 68% use AI agents weekly for personal tasks, half are uncomfortable letting AI handle credit card purchases. Only 15% would share financial info with AI, and 43% lack confidence in spotting fraudu...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
Known, a company developing accountability infrastructure for autonomous AI, announced that Edna Conway, former senior security executive at Microsoft and Cisco, has joined its Advisory Council. Conway brings extensive experience in cybersecurity and...
Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...
